Af­ter a year of tu­mult, Pfiz­er man­ages to pull off a bor­ing quar­ter

Some­times no news is good news.

On Tues­day, Pfiz­er de­liv­ered an un­event­ful up­date to in­vestors with its sec­ond-quar­ter earn­ings re­sults. It was a wel­come re­prieve …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER